Literature DB >> 1832927

Distribution of Photofrin between tumour cells and tumour associated macrophages.

M Korbelik1, G Krosl, P L Olive, D J Chaplin.   

Abstract

Photofrin levels in cells derived from SCCVII tumours, excised from mice that previously received the drug, were measured using a fluorescence activated cell sorter (FACS). Concomitantly, in the same cells the FACS was used to measure fluorescein isothiocyanate (FITC) fluorescence that originated from FITC-conjugated antimouse IgG added to the cell suspension before sorting. This later measurement enabled discrimination between IgG negative tumour malignant cells and IgG positive host cells (primarily macrophages). In addition, cellular Photofrin content in 'tumour' and 'host' cells sorted by FACS was determined by chemical extraction. The measurements were performed for the time intervals 1-96 h post Photofrin administration. The data showed consistently higher Photofrin levels in the 'host cells', i.e., tumour associated macrophages (TAM), than in 'tumour' cells. On a per cell basis, at any time point studied there was a minimum of 1.7 times more Photofrin in 'host' than in 'tumour cells', while at 4-12 h postadministration, ratios of up to 3.0 times were observed. This corresponds to ratio values greater than 9, when based on Photofrin content per micrograms cell protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832927      PMCID: PMC1977627          DOI: 10.1038/bjc.1991.339

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Cellular delivery and retention of Photofrin II: the effects of interaction with human plasma proteins.

Authors:  M Korbelik; J Hung
Journal:  Photochem Photobiol       Date:  1991-04       Impact factor: 3.421

2.  Photofrin uptake by murine macrophages.

Authors:  M Korbelik; G Krosl; D J Chaplin
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

3.  Distribution, oxygenation, and clonogenicity of macrophages in a murine tumor.

Authors:  P L Olive
Journal:  Cancer Commun       Date:  1989

4.  Release of prostaglandin E2 from cells by photodynamic treatment in vitro.

Authors:  B W Henderson; J M Donovan
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

5.  Intermittent blood flow in a murine tumor: radiobiological effects.

Authors:  D J Chaplin; P L Olive; R E Durand
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

6.  Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages.

Authors:  D H Lynch; S Haddad; V J King; M J Ott; R C Straight; C J Jolles
Journal:  Photochem Photobiol       Date:  1989-04       Impact factor: 3.421

7.  Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability.

Authors:  L Milas; J Wike; N Hunter; J Volpe; I Basic
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

8.  Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors.

Authors:  W S Chan; J F Marshall; G Y Lam; I R Hart
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

Review 9.  Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction.

Authors:  B W Henderson; D A Bellnier
Journal:  Ciba Found Symp       Date:  1989

Review 10.  In vivo transport and pharmacokinetic behavior of tumour photosensitizers.

Authors:  G Jori
Journal:  Ciba Found Symp       Date:  1989
View more
  7 in total

1.  The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy.

Authors:  Mladen Korbelik; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-01-26       Impact factor: 3.982

Review 2.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

3.  Sputum analysis by flow cytometry; an effective platform to analyze the lung environment.

Authors:  Lydia H Bederka; Jamila R Sanchez; Jennifer Rebeles; Patricia R Araujo; Marcia H Grayson; Shao-Chiang Lai; Louis R DePalo; Sheila A Habib; David G Hill; Kathleen Lopez; Lara Patriquin; Robert Sussman; James Humphreys; Xavier T Reveles; Vivienne I Rebel
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

4.  Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.

Authors:  J C Bremner; G E Adams; J K Pearson; J M Sansom; I J Stratford; J Bedwell; S G Bown; A J MacRobert; D Phillips
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

5.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.

Authors:  G Krosl; M Korbelik; G J Dougherty
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

6.  Photofrin accumulation in malignant and host cell populations of various tumours.

Authors:  M Korbelik; G Krosl
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

7.  Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply.

Authors:  M Korbelik; G Krosl
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.